K

A

Atrandi Biosciences

Healthcare & Life Sciences

Recent Finacing

Series A

Recent Raise

$25M


Atrandi Biosciences specializes in single-cell analysis technology, providing advanced microfluidic devices and high-throughput screening platforms.

Total Funding

$25M

Headquarters

Vilnius, Lithuania

Founded

N/A

Focus Areas

Single-cell analysis
semi-permeable capsule
microfluidic device
droplet generator
high-throughput screening.

Investors

Practica Capital logo
Lux Capital logo
Metaplanet logo
Vsquared Ventures logo
GRIDS Capital logo